Cargando…
The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
Vaccines against Japanese encephalitis (JE) have been available for decades. Currently, most JE-endemic countries have vaccination programs for their at-risk populations. Even so, JE remains the leading recognized cause of viral encephalitis in Asia. In 2018, the U.S. Centers for Disease Control and...
Autores principales: | Vannice, Kirsten S., Hills, Susan L., Schwartz, Lauren M., Barrett, Alan D., Heffelfinger, James, Hombach, Joachim, Letson, G. William, Solomon, Tom, Marfin, Anthony A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206071/ https://www.ncbi.nlm.nih.gov/pubmed/34131150 http://dx.doi.org/10.1038/s41541-021-00338-z |
Ejemplares similares
-
Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
por: Hills, Susan, et al.
Publicado: (2009) -
Neuropsychiatric Sequelae of Japanese encephalitis (JE)
por: Singhai, Samiksha, et al.
Publicado: (2022) -
Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016
por: Heffelfinger, James D., et al.
Publicado: (2017) -
Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against
Circulating Heterologous JE Virus Genotypes
por: Erra, Elina O., et al.
Publicado: (2013) -
Japanese Encephalitis Virus as Cause of Acute Encephalitis, Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2020)